Midway through trading Thursday, the Dow traded down 0.23
percent to 14,477.96 while the NASDAQ dropped 0.61 percent to
3,234.34. The S&P also fell, dropping 0.31 percent to
Index Technicals: The S&P 500 seems to be stalling at
1,562 before heading lower this morning, with support set at
1,550, and 1,540 below.
The Dow also seems to be stalling, slowing down at the 14,547
and heads lower to test 14,450 support with 14,400 support below
Next, the Russell looks to have resistance at 952, while
gapping down to test its 945 support, with 939 acting as a level
Finally, the NASDAQ looks set to test its 3,258 resistance,
and gap lower this morning to test its support at 3,212.
Top Headline Yesterday, Oracle (NASDAQ:
) reported downbeat fiscal third-quarter results. Oracle's
quarterly earnings came in at $2.5 billion, or $0.52 per share,
versus $2.5 billion, or $0.49 per share, in the year-ago period.
Its adjusted earnings came in at $0.65 per share. Its revenue
fell 1% to $8.96 billion from $9.04 billion. However, analysts
were expecting earnings of $0.66 per share on revenue of $9.38
billion. Analysts including Evercore Partners and CLSA also
downgraded the stock following the news. Equities Trading UP
ACADIA Pharmaceuticals (NASDAQ:
) shot up 27.91 percent to $8.51 after phase III pimavanserin
study data. Shares of SUPERVALU (NYSE:
) got a boost, shooting up 8.83 percent to $4.56 after the
company completed the sale of five retail grocery banners in a
stock deal valued at $3.3 billion. Herman Miller (NASDAQ:
) was also up, gaining 8.52 percent to $27.63 after the company
reported upbeat Q3 earnings.
Equities Trading DOWN Scholastic (NASDAQ:
) shares tumbled 14.03 percent to $26.71 after the company
reported a wider fiscal third-quarter loss. Oracle (NASDAQ:
) was also down, falling 8.26 percent to $32.81 after the company
reported downbeat fiscal third-quarter results.
Shares of Guess' (NYSE:
) were down 4.06 percent to $25.86 after the company issued
Commodities In commodity news, oil traded down 0.49 percent to
$93.04, while gold traded up 0.31 percent to $1,612.50. Silver
traded up 1.28 percent Thursday to $29.19, while copper dropped
0.19 percent to $3.44.
Eurozone European shares were weaker on the PMI data overnight
as well as continued uncertainty over Cyprus' bailout; the
Mediterranean nation continues talks with Russian creditors today
and no deal has been reached yet. Germany's manufacturing sector
showed a renewed contraction after two months of expansion as the
manufacturing PMI fell to 48.9 from 50.3 on expectations of a
rise to 50.5. The Spanish Ibex Index tumbled 0.77 percent and the
Italian FTSE MIB Index dipped 0.50 percent. The STOXX Europe 600
Index dropped 0.71 percent, London's FTSE 100 Index fell 0.66
percent, French CAC 40 Index fell 1.14 percent and German DAX 30
index declined 0.89 percent. Economics US jobless claims rose
2,000 to 336,000 in the week ended March 16. However, economists
were expecting claims to increase to 340,000. Continuing claims
gained 5,000 to 3.05 million in the week ended March 9. US home
prices rose 0.6% in January, according to the Federal Housing
Finance Agency. The US flash manufacturing PMI increased to 54.9
in March, versus 54.3 in February. The Bloomberg Consumer Comfort
Index declined to minus 33.9 in the week ended March 17, versus a
prior reading of minus 31.6. USA Philadelphia Fed Manufacturing
Index for March 2.00, versus estimates of -3.00. The prior
reading was -12.50. USA Existing Home Sales for Feb rose 0.8% to
4.98 million, versus estimates of 5.0 million. USA Leading
Indicators for Feb 0.50%, versus economists' estimates of 0.40%.
The prior reading was revised from an initial 0.20% to 0.50%.
Natural gas supplies declined 62 billion cubic feet for the week
ended March 15, the Energy Information Administration reported.
However, analysts were expecting a fall between 67 billion and 71
billion cubic feet.
(c) 2013 Benzinga.com. Benzinga does not provide investment
advice. All rights reserved.
Profit with More New & Research
. Gain access to a streaming platform with all the information
you need to invest better today.
Click here to start your 14 Day Trial of Benzinga